The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Podcasts
Michael Neely introduces the topic of risk sharing as it is becoming more popular in healthcare and how it can improve patient care while lowering
Podcasts
In this short webcast, Chris Wiekert will take you through the steps he used to lead his department in a culture change from one with poor service
Podcasts
In this informational session, Karen Conway discusses her research with the FDA on value and the UDI.
Podcasts
Explore the new delivery methods of health care, how community resources and organizations are now working together to reduce patient episodic care
Podcasts
In this short webcast, Dena Jackson and Sophie Rutherford discuss connecting the organization to the supply chain department in order to build coll
Podcasts
Teresa Dail, AHRMM’s 2018 Chair, shares AHRMM’s definition of clinical integration and why a clinically integrated supply chain is important to her